Since Dr. Rubinstein began his tenure as Interim CMO in September 2025, the company has achieved significant clinical and ...

Andover-based TransMedics Group signed a 498K SF lease for 188 Assembly Park Drive at BioMed Realty 's Assembly Innovation ...

Hong Kong investors can now trade in their first mRNA concept stock, following the strong trading debut for Suzhou Ribo Life ...

FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company" or "Solid"), a life sciences company developing precision genetic medicines for neuromuscular ...

GRIN Therapeutics begins patient dosing in global phase 3 Beeline trial of investigational radiprodil for GRINRelated neurodevelopmental disorder: New York Monday, January 12, 202 ...

It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

OP-ED. Hemmed in by domestic and external crises, the Islamic Republic of Iran is now finding itself with nowhere left to ...

Scientists observing the red giant star R Doradus have found that starlight isn’t strong enough to drive its stellar winds, ...

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments ...

US FDA accepts Camurus’ resubmission of NDA for Oclaiz for treatment of acromegaly: Lund, Sweden Monday, January 12, 2026, 15:00 Hrs [IST] Camurus, an international, science-led ...